Beirut – MSD in Lebanon, (known as Merck & Co in the US and Canada) today announced a cash and medicines donation valued at more than $500,000 to the healthcare sector in Lebanon. This donation is in response to calls for support by the Prime Minister during the COVID-19 outbreak in Lebanon.

The donation will support various institutions, hospitals and medical associations in their ongoing efforts against the COVID-19 outbreak. Furthermore, the cash and medicines donation will be used to deliver healthcare to patients who are suffering from many conditions such as cancer and whose access to routine health care may have been interrupted during the containment stage.

“We are grateful to the Government and to all healthcare providers for everything that they are doing to protect the Lebanese people and to ensure their wellbeing and safety during this global public health crisis,” said Okan Isikci, General Manager of MSD Levant. “We recognize that the officials are experiencing challenges never-before anticipated. We also want to thank all the healthcare workers and those on the front lines of this health crisis who are treating and saving as many lives as they can. We say Thank You and we salute you.”

MSD is focused on protecting the safety of its employees and their families, ensuring that our supply of medicines and vaccines reach our patients, contributing our scientific expertise to the development of antiviral approaches, and supporting our healthcare providers and our communities.  MSD has also launched a program to enable our medically trained employees to volunteer their time to aid their communities while maintaining their base pay. This volunteering includes several members of MSD staff in the Levant.

Send us your press releases to pressrelease.zawya@refinitiv.com 

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.